Surgery Partners (NASDAQ:SGRY) Stock Rating Cut to “Hold” at TD Cowen

TD Cowen lowered shares of Surgery Partners (NASDAQ:SGRY – Free Report) from a strong-buy rating to a hold rating in a research report report published on Saturday,Zacks reports.

Other research analysts also recently issued reports about the company. Benchmark reissued a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. UBS Group cut Surgery Partners from a “buy” rating to a “hold” rating and raised their price target for the company from $21.00 to $23.50 in a report on Wednesday, October 28th. Weiss Ratings raised Surgery Partners from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 16th. Cantor Fitzgerald downgraded Surgery Partners from an “overweight” rating to a “hold” rating in a research report on Monday, October 26th. Finally, Raymond James Financial set a $23.50 price objective on Surgery Partners in a research note on Monday, October 26th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Surgery Partners has an average rating of “Hold” and an average price target of $20.14.

Get Our Latest Stock Report on Surgery Partners

Surgery Partners Trading Down 0.4%

Shares of SGRY stock opened at $23.12 on Friday. The company has a market capitalization of $3.03 billion, a P/E ratio of -33.03, a P/E/G ratio of 7.19 and a beta of 1.90. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $23.37. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The firm has a 50-day moving average price of $15.30 and a 200 day moving average price of $14.68.

Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. The firm had revenue of $848.90 million for the quarter, compared to analysts’ expectations of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.17 earnings per share. Research analysts forecast that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Insider Transactions at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the transaction, the director directly owned 66,843 shares in the company, valued at $959,197.05. The trade was a 17.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Surgery Partners

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Swiss National Bank lifted its holdings in Surgery Partners by 1.1% in the first quarter. Swiss National Bank now owns 153,500 shares of the company’s stock valued at $1,830,000 after buying an additional 1,700 shares during the period. PNC Financial Services Group Inc. boosted its stake in Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after acquiring an additional 2,051 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in Surgery Partners in the second quarter valued at approximately $38,000. Fifth Third Bancorp grew its holdings in Surgery Partners by 5,324.0% during the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after acquiring an additional 3,993 shares during the period. Finally, Inspire Investing LLC grew its holdings in Surgery Partners by 10.1% during the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock worth $621,000 after acquiring an additional 4,099 shares during the period.

Trending Headlines about Surgery Partners

Here are the key news stories impacting Surgery Partners this week:

  • Positive Sentiment: Bon Secours Mercy Health’s proposed $23.50-per-share acquisition provides a clear valuation reference and supports the share price. Bain Capital, Surgery Partners’ largest shareholder, plans to roll its equity into the combined company, signaling substantial shareholder participation. Surgery Partners stock enters take-private focus after HealthSpan deal
  • Neutral Sentiment: The consensus price target was raised 15.45% to $22.61, reflecting improved valuation expectations, but the target is below the merger offer and therefore provides limited incremental support while the transaction remains pending. Surgery Partners consensus price target increased by 15.45% to $22.61
  • Negative Sentiment: KeyCorp reduced its FY2026 EPS forecast to $0.07 from $0.16 and cut its FY2027 forecast to a $0.21-per-share loss from expected earnings of $0.13. It also lowered its Q3 2026 estimate to a $0.13 loss, while forecasting a $0.08 loss for Q4. These revisions point to weaker near-term profitability than previously expected.
  • Negative Sentiment: Multiple law firms are investigating the $23.50 merger, including whether Surgery Partners’ directors breached fiduciary duties and whether the transaction adequately serves shareholders. Such investigations may increase deal uncertainty, although these notices do not by themselves indicate that wrongdoing occurred. SGRY shareholder merger investigation Scott+Scott Surgery Partners investor alert

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.

Featured Stories

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.